Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07318493 · ClinicalTrials.gov registry record · NA
Antiseptic-Coated Sutures and Pancreatic Fistula Risk After Pancreatoduodenectomy
A NA study of Pancreatoduodenectomy and Whipple Procedure, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 436
- Enrollment target
- 3
- Study locations
NCT07318493: Recruiting NA study of Pancreatoduodenectomy and Whipple Procedure, sponsored by The Cleveland Clinic.
NCT07318493 is a NA study of Pancreatoduodenectomy and Whipple Procedure that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 436 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07318493, a NA study of Pancreatoduodenectomy and Whipple Procedure, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 436 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to determine if the use of antiseptic-coated sutures is better than the use of the standard sutures in preventing postoperative fistulas within 90 days after pancreatoduodenectomy.
Primary Outcome
comparison of the rate of postoperative pancreatic fistula- Biochemical leak
Conditions Studied
Interventions
- DEVICE Standard (non-antiseptic coated) suture will be used.
- DEVICE Triclosan/antiseptic -coated suture
Study Locations (3)
Ohio
- Cleveland Clinic Akron - Akron
- Cleveland Clinic - Cleveland
- Cleveland Clinic Fairview Hospital - Fairview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 436 participants |
| Start Date | 2026-01-13 |
| Est. Completion | 2031-02 |
| Phase | NA |
What NCT07318493 shows while recruiting
NCT07318493 is an interventional study that assigns participants to a tested intervention. The registered 436 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with Pancreatoduodenectomy appearing as the primary indexed condition, and to 2 interventions - of which Standard (non-antiseptic coated) suture will be used. is the first listed.
NCT07318493 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07318493 about?
NCT07318493 is a clinical study titled "Antiseptic-Coated Sutures and Pancreatic Fistula Risk After Pancreatoduodenectomy". The purpose of this study is to determine if the use of antiseptic-coated sutures is better than the use of the standard sutures in preventing postoperative fistulas within 90 days after pancreatoduodenectomy.
What is the current status of trial NCT07318493?
This trial is currently recruiting. It is a NA study. The enrollment target is 436 participants. The study started on 2026-01-13. Estimated completion is 2031-02.
What conditions does trial NCT07318493 study?
This clinical trial studies the following conditions: Pancreatoduodenectomy, Whipple Procedure.
What interventions are being tested in trial NCT07318493?
The interventions under investigation include: Standard (non-antiseptic coated) suture will be used. (DEVICE), Triclosan/antiseptic -coated suture (DEVICE).
Who is sponsoring clinical trial NCT07318493?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07318493 being conducted?
This trial has 3 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07318493's enrollment target sits among peer trials
436 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02622542 · 436 participants · NA
ACute Uncomplicated Type b Aortic Dissection: Endovascular Repair vs. Best Medical Therapy
- NCT05918211 · 436 participants · Phase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
- NCT06966479 · 436 participants · Phase 2
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
- NCT05563220 · 435 participants · Phase 1
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI